Atopy, asthma, and experimental approaches based on the linear model of T cell maturation

Clinical and Experimental Allergy

Volumn 35, Issue 1, 2005, Pages 8-17

  Loza, Matthew J ^a   Peters, S P ^a   Penn, R B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4 RECEPTOR; PROSTAGLANDIN E2;

ALLERGIC ASTHMA; ALLERGY; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPY; BACTERIAL INFECTION; BRONCHODILATING ACTIVITY; BRONCHOSPASM; CELL MATURATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DOWN REGULATION; GENETIC VARIABILITY; HUMAN; HYGIENE; IMMUNE RESPONSE; IN VITRO STUDY; INDUSTRIALIZATION; LONG TERM CARE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MODEL; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; VIRUS INFECTION;

ASTHMA; BYSTANDER EFFECT; CELL DIFFERENTIATION; CYTOKINES; HUMANS; HYPERSENSITIVITY; INTERFERON TYPE II; MODELS, ANIMAL; RESEARCH DESIGN; T-LYMPHOCYTES;

EID: 13244264811     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02148.x     Document Type: Review

References (59)

1. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
2. Busse WW, Lemanske RF Jr. Advances in immunology: asthma. N Engl J Med 2001; 344:350-62.
3. Shaver JR, O'Connor JJ, Pollice M et al. Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects. Am J Respir Crit Care Med 1995; 152:1189-97.
4. Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299:1259-60.
5. Loza MJ, Zamai L, Azzoni L, Rosati E, Perussia B. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood 2002; 99:1273-81.
6. Loza MJ, Peters SP, Zangrilli JG, Perussia B. Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4. Eur J Immunol 2002; 32:413-23.
7. Loza MJ, Perussia B. Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation? Nat Immunol 2001; 2:917-24.
8. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76:241-51.
9. Swain SL, Bradley LM, Croft M et al. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev 1991; 123:115-44.
10. Romagnani S. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Arch Allergy Immunol 1992; 98:279-85.
11. Manetti R, Parronchi P, Giudizi MG et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993; 93:1199-204.
12. Swain S, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145:3796-806.
13. Loza MJ, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type I cytokine production. J Immunol 2002; 169:3061-8.
14. Loza MJ, Perussia B. Accumulation of type 2 cytokine+ T cells: differentiation-independent proliferation of pre-existing type 2 T cells. Eur J Immunol 2003; 33:939-49.
15. Noben-Trauth N, Hu-Li J, Paul WE. Conventional, naive CD4+ T cells provide an initial source of IL-4 during Th2 differentiation. J Immunol 2000; 165:3620-5.
16. Agarwal N, Nir I, Papermaster DS. Loss of diurnal arrestin gene expression in rds mutant mouse retinas. Exp Eye Res 1994; 58:1-8.
17. Grogan J, Mohrs M, Harmon B, Lacy DA. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 2001; 14:205-15.
18. Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Paul WE, Sher A. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a type 2 cytokine profile. J Immunol 2000; 164:3047-55.
19. Kropf P, Schopf LR, Chung CL et al. Expression of Th2 cytokines and the stable Th2 marker ST2L in the absence of IL-4 during Leishmania major infection. Eur J Immunol 1999; 29:3621-8.
20. Bancroft AJ, Artis D, Donaldson DD, Sypek JP, Grencis RK. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent. Eur J Immunol 2000; 30:2083-91.
21. Kamogawa Y, Minasi LE, Carding SR, Bottomly K, Flavell RA. The relationship of IL-4 and IFN-g-producing T cells studied by ablation of IL-4-producing cells. Cell 1993; 75:985-95.
22. + thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10. Eur J Immunol 1996; 26:1083-7.
23. Stephens R, Chaplin DD. IgE cross-linking or lipopolysaccharide treatment induces recruitment of Th2 cells to the lung in the absence of specific antigen. J Immunol 2002; 169:5468-76.
24. Stephens R, Randolph DA, Huang G, Holtzman MJ, Chaplin DD. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J Immunol 2002; 169:5458-67.
25. Biron CA. Interferons alpha and beta as immune regulators - a new look. Immunity 2001; 14:661-4.
26. Dinarello CA. Interleukin-18. Methods 1999; 19:121-32.
27. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type I and cytotoxic lymphocytes. [Review]. Blood 1994; 94:4008-27.
28. De Heer HJ, Hammad H, Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200:89.
29. Hakonarson H, Kim C, Whelan R, Campbell D, Grunstein MM. Bi-directional activation between human airway smooth muscle cells and T lymphocytes: role in induction of altered airway responsiveness. J Immunol 2001; 166:293-303.
30. Castro M, Chaplin DD, Walter MJ, Holtzman MJ. Could asthma be worsened by stimulating the T-helper type 1 immune response? Am J Respir Cell Mol Biol 2000; 22:143-6.
31. Ball TM, Castro-Rodriguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med 2000; 343:538-43.
32. Colavita AM, Reinach AJ, Peters SP. Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm. Clin Chest Med 2000; 21:263-77.
33. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. J Allergy Clin Immunol 2000; 105:193-204.
34. Holtzman MJ, Morton JD, Shornick LP et al. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol Rev 2002; 82:19-46.
35. Randolph DA, Stephens R, Carruthers CJ, Chaplin DD. Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation. J Clin Invest 1999; 104:1021-9.
36. Holtzman MJ, Sampath D, Castro M, Look DC, Jayaraman S. The one-two of T helper cells: does interferon-gamma knock out the Th2 hypothesis for asthma? Am J Respir Cell Mol Biol 1996; 14:316-8.
37. Krug N, Madden J, Redington AE et al. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996; 14:319-26.
38. Peebles RS Jr, Hashimoto K, Morrow JD et al. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2002; 165:1154-60.
39. Betz M, Fox BS. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146:108-13.
40. Bauman GP, Bartik MM, Brooks WH, Roszman TL. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation. Cell Immunol 1994; 158:182-94.
41. Billington CK, Penn RB. Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res 2003; 4:2.
42. Leone FT, Fish JE. Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma. Chest 2003; 124:2329-40.
43. Sears MR, Taylor DR, Print CG et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336:1391-6.
44. Spitzer WO, Suissa S, Ernst P et al. The use of β-agonists and the risk of death and near-death from asthma. N Engl J Med 1992; 326:501-6.
45. Taylor DR, Town GI, Herbison GP et al. Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol. Thorax 1998; 53:744-52.
46. Wooltorton E. Salmeterol (Serevent) asthma trial halted early. Cmaj 2003; 168:738.
47. Howard TD, Postma DS, Hawkins GA et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002; 110:743-51.
48. Deichmann K, Bardutzky J, Forster J, Heinzmann A, Kuehr J. Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 1997; 231:696-7.
49. Hackstein H, Hecker M, Kruse S et al. A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 2001; 53:264-9.
50. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337:1720-5.
51. Kruse S, Japha T, Tedner M et al. The polymorphisms S503P and Q576R in the interleukinn-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 1999; 96:365-71.
52. Mitsuyasu H, Izuhara K, Mao XQ et al. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19:119-20.
53. Ober C, Leavitt SA, Tsalenko A et al. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000; 66:517-26.
54. Howard TD, Koppelman GH, Xu J et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002; 70:230-6.
55. Hall IP, Wheatley A, Christie G, McDougall C, Hubbard R, Helms PJ. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999; 354:1264-5.
56. Hellings PW, Vandenberghe P, Kasran A et al. Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur J Immunol 2002; 32:585-94.
57. Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 1999; 162:5784-91.
58. Murphy ML, Cotterell SE, Gorak PM, Engwerda CR, Kaye PM. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J Immunol 1998; 161:4153-60.
59. Loza MJ, Faust JS, Perussia B. Multiple color immunofluorescence for cytokine detection at the single-cell level. Mol Biotechnol 2003; 23:245-58.